MP4

November 29, 2021

TransCelerate Town Hall: Nov. 16, 2021

On November 16, Board Members Dietmar Berger (Sanofi), Martin Lange (Novo Nordisk), and Rob Metcalf (Eli Lilly) joined TransCelerate COO Janice Chang for a one-hour session focused on the state of our collaboration and insights into the future of TransCelerate. Moderated by TransCelerate VP of Communications and Engagement, Jennifer Burgess, the panel discussed the importance of learning from the COVID-19 pandemic and taking those learnings into everything we do. The panel also highlighted recent successes from across the TransCelerate organization and provided an optimistic outlook for the future of clinical research and the importance of trusted collaboration to get to the desired future outcomes.

Explore

November 12, 2021

Keynote Speaker: Andrew Schorr

Andrew Schorr of Carlsbad, California near San Diego is a medical journalist who, working in partnership with his wife, Esther, has devoted his life to educating and empowering families affected by serious illnesses since 1984. First as the producer of brief educational videos and, more recently hosting worldwide broadcasts on the Internet, Andrew and his team have touched the lives of several million patients. They have won numerous national awards for the quality and impact of their work.

Andrew is the author of The Web-Savvy Patient: An Insider's Guide to Navigating the Internet When Facing Medical Crisis, published in the spring of 2011. In the book, Andrew shares the real-life success stories of powerful patients to help individuals feel confident using the Internet to find reliable medical information, connect with others, and use what they learn in effective conversations with their doctor.

The audience will hear firsthand from Andrew about the challenges that patients face navigating clinical research and discuss how the TransCelerate solutions have a direct impact on meeting those challenges and improving the patient experience.

Explore

November 12, 2021

The Future Landscape of Clinical Research – A TransCelerate Perspective

What does clinical research look like in the year 2030? Hear directly from the experts who are part of designing and delivering TransCelerate’s transformational work that is designed to modernize clinical research. The audience will learn first-hand how the solutions available from TransCelerate today lay the foundation for clinical trials of the future.

Explore

November 12, 2021

The Application of Intelligent Automation Technologies in PV

Biopharmaceutical companies and other industry experts have been encouraged to design clinical trials with a keen focus on improving the patient experience. To this end, TransCelerate has created numerous tools, assets, and methodologies to not only help improve the patient experience within current clinical trials, but also with the aim of learning from patient experiences so that future clinical studies can be better designed with the patient’s perspective in mind.

From pre-diagnosis through clinical trial completion, this session will explore several available TransCelerate tools and assets delivered to improve the clinical trial participation journey for patients. This session will also address when to consider utilizing each tool during the patient’s clinical trial participation journey and discuss best practices in the adoption / implementation of these tools.

Explore

November 12, 2021

From Subject to Superstar: How to Put Patients in the Driver Seat in Clinical Trials (Part 2)

Biopharmaceutical companies and other industry experts have been encouraged to design clinical trials with a keen focus on improving the patient experience. To this end, TransCelerate has created numerous tools, assets, and methodologies to not only help improve the patient experience within current clinical trials, but also with the aim of learning from patient experiences so that future clinical studies can be better designed with the patient’s perspective in mind.

From pre-diagnosis through clinical trial completion, this session will explore several available TransCelerate tools and assets delivered to improve the clinical trial participation journey for patients. This session will also address when to consider utilizing each tool during the patient’s clinical trial participation journey and discuss best practices in the adoption / implementation of these tools.

Explore

November 12, 2021

From Subject to Superstar: How to Put Patients in the Driver Seat in Clinical Trials (Part 1)

Biopharmaceutical companies and other industry experts have been encouraged to design clinical trials with a keen focus on improving the patient experience. To this end, TransCelerate has created numerous tools, assets, and methodologies to not only help improve the patient experience within current clinical trials, but also with the aim of learning from patient experiences so that future clinical studies can be better designed with the patient’s perspective in mind.

From pre-diagnosis through clinical trial completion, this session will explore several available TransCelerate tools and assets delivered to improve the clinical trial participation journey for patients. This session will also address when to consider utilizing each tool during the patient’s clinical trial participation journey and discuss best practices in the adoption / implementation of these tools.

Explore

November 12, 2021

Interpretations of New PV Guidances and Regulations

Historically, there have been challenges in addressing ambiguous regulations / guidance and Health Authority operational expectations. In this session, we will speak about the close collaboration between TransCelerate member companies to understand how each is interpreting and implementing regulations and guidances including: IND Reporting, Reference Safety Information, Postmarketing Safety Reporting for Combination Products, Safety Issue Notifications, IND Safety Reporting to FAERS, and Presentation of Risks Throughout the Lifecycle.

This session will also address best practices across the industry / learnings from feedback from regulators.

Explore

November 12, 2021

Evidence-Based Approach to Improving Drug Safety Activities/Processes

The pharmacovigilance space is ripe for collaboration as the biopharmaceutical industry experiences challenges in drug safety surveillance. In this session, we will speak about the delivered TransCelerate solutions to improve patient safety across the value chain and best practices for implementation. We will address solutions from several TransCelerate initiatives including: Value of Safety Information Data Sources, Interpretation of Pharmacovigilance Guidances and Regulations, Intelligent Automation Opportunities in Pharmacovigilance, and Pharmacovigilance Agreements Optimization.

Explore

November 12, 2021

Symposium Welcome and Leadership Panel

Since 2012, TransCelerate’s mission has been to improve the health of people around the globe by accelerating and simplifying the research and development of innovative new therapies.

In order to fulfill this mission, TransCelerate engages in robust partnerships with organizations across the ecosystem that provide important insights and perspectives that enable us to create value and sustainable industry change.

This leadership panel consists of senior R&D leaders who represent the perspectives of several key stakeholders across the ecosystem.

The panel will address at a high level the importance of collaboration in the future of clinical research and provide real examples of the impact of collaboration being realized today.

Explore

October 12, 2020

Lung Cancer – Linnea Olson Patient Story

Linnea Olson, a patient with lung cancer who has participated in multiple clinical trials over a long period of time, discusses how clinical trials have changed her life, and shares her views on clinical trials as a treatment option.

Explore